Tretinoin clinical trials
Also written ATRA, Vesanoid and Retin-A.
Includes 2 studies of Tretinoin Liposome.
How each study uses Tretinoin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Tretinoin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Oct 1971 · RETIN-A · NDA 016921 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
143 studies that test it; most in 2025 (11)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1993 | 2 |
| 1995 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 5 |
| 2000 | 2 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 7 |
| 2009 | 10 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 21 · Other 122
Peking University People's Hospital (7) · M.D. Anderson Cancer Center (5) · Bausch Health Americas, Inc. (5) · Gruppo Italiano Malattie EMatologiche dell'Adulto (4) · Fudan University (4) · Merck Sharp & Dohme LLC (3) · Johns Hopkins University (3) · Memorial Sloan Kettering Cancer Center (3)
Often tested with
Tested in the same studies.
Arsenic Trioxide (11) · Azacitidine (7) · Adapalene (5) · Venetoclax (4) · Valproic Acid (4) · Cytarabine (4) · Vibostolimab (3) · Benzoyl Peroxide (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 8
Studies that test Tretinoin.
- Jan 2027Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication SyndromePhase 2 · Second Affiliated Hospital, School of Medicine, Zhejiang University
- Mar 2027ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.Phase 1 · Daniel Breadner
- May 2027Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane WartsNot applicable · Combined Military Hospital, Pakistan
- Jun 2027ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCTPhase 2 · Ruijin Hospital
- Jul 2027Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid TumorsPhase 2 · University of Utah
- Jul 2027Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic LeukemiaNot applicable · Anhui Medical University
- Oct 2027Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsPhase 2 · Peking University People's Hospital
- Oct 2027Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsPhase 2 · Peking University People's Hospital
Studies
Open first, then newest update. How each study uses Tretinoin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 143
- Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaRecruitingPhase 2M.D. Anderson Cancer CenterNCT01409161Written as TretinoinHow we know
- Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane WartsNot yet recruitingNot applicableCombined Military Hospital, PakistanNCT07927920Written as Tretinoin 0.05% creamHow we know
- Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaNot yet recruitingPhase 1/2Second Affiliated Hospital of Nanchang UniversityNCT07926607Written as All-trans retinoic acidHow we know
- Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced LeiomyosarcomaRecruitingPhase 2Gabriel TinocoNCT06528769Written as all-trans retinoic acidHow we know
- Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of EpendymomaNot yet recruitingPhase 1/2Children's Oncology GroupNCT07848568Written as TretinoinHow we know
- Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceNot yet recruitingPhase 1Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07842887Written as All-trans retinoic acidHow we know
- All-Trans Retinoic Acid for the Treatment of Hemophagocytic LymphohistiocytosisNot yet recruitingPhase 2/3Beijing Anzhen HospitalNCT07626398Written as ATRAHow we know
- ATRA for Management of Primary ITPNot yet recruitingPhase 3Peking University People's HospitalNCT07597395Written as all-trans retinoic acid (ATRA)How we know
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingPhase 2Peking University People's HospitalNCT07586813Written as All-trans retinoic acidHow we know
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingPhase 2Peking University People's HospitalNCT07586826Written as All-trans retinoic acidHow we know
- Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck CarcinomaRecruitingPhase 3Centre Leon BerardNCT06706401Written as VesanoidHow we know
- ATRA and Carfilzomib in Plasma Cell Myeloma PatientsRecruitingPhase 1/2The Methodist Hospital Research InstituteNCT06536413Written as All-Trans Retinoic Acid (ATRA) Dose 0How we know
- Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid TumorsRecruitingPhase 2University of UtahNCT06358677Written as Topical TretinoinHow we know
- A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk RhabdomyosarcomaNot yet recruitingPhase 2Fudan UniversityNCT07355855Written as ATRA+VACHow we know
- ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.Not yet recruitingPhase 1Daniel BreadnerNCT07348107Written as ATRAHow we know
- Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune ThrombocytopeniaNot yet recruitingPhase 2/3Institute of Hematology & Blood Diseases Hospital, ChinaNCT07278908Written as Avatrombopag+All trans retinoic acidHow we know
- Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid CancerRecruitingPhase 1/2Gustave Roussy, Cancer Campus, Grand ParisNCT06439888Written as all-trans retinoic acidHow we know
- Reverse HER2-negative Immune Resistant Breast CancerRecruitingPhase 2Fudan UniversityNCT06731140Written as Retinoic AcidHow we know
- Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication SyndromeNot yet recruitingPhase 2Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT07079696Written as ATRAHow we know
- Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid LeukemiaEnrolling by invitationPhase 1/2Institute of Hematology & Blood Diseases Hospital, ChinaNCT03031249Written as all-trans retinoic acidHow we know
See all 143 studies that test Tretinoin →
Given beside what is tested · 33 — Tretinoin is usual care or a partner of the new treatment
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingPhase 3Quetzal TherapeuticsNCT07504458Written as QTX-2101 + ATRAHow we know
- Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate AcneRecruitingPhase 4Nishtar Medical UniversityNCT07915648Written as Tretinoin Cream 0.025%How we know
- Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).RecruitingPhase 3First Affiliated Hospital Xi'an Jiaotong UniversityNCT07503730Written as ATRAHow we know
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaRecruitingPhase 2Stephen Bagley, MD, MSCENCT05345002Written as All-trans retinoic acidHow we know
- A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)Not yet recruitingPhase 3SDK Therapeutics, Inc.NCT07296445Written as all-trans retinoic acid (ATRA)How we know
- A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.RecruitingNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT06371274Written as ATRAHow we know
- Treatment Study for Children and Adolescents With Acute Promyelocytic LeukemiaRecruitingPhase 2Associazione Italiana Ematologia Oncologia PediatricaNCT04793919Written as All-trans retinoic acidHow we know
- Sirolimus Combined With ATRA for the Treatment of Auto-Immune AnemiaWithdrawnPhase 4Peking Union Medical College HospitalNCT04324411Written as sirolimus and ATRAHow we know
- Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic LeukemiaCompletedPhase 3Technische Universität DresdenNCT02688140Written as TretinoinHow we know
- Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast CancerTerminatedPhase 2Mario Negri Institute for Pharmacological ResearchNCT04113863Written as all-trans retinoic acidHow we know
- An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesTerminatedPhase 1/2Incyte CorporationNCT02712905Written as all-trans retinoic acid (ATRA)How we know
- The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9CompletedPhase 3Peking University People's HospitalNCT05438875Written as all-trans retinoic acidHow we know
- A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple MyelomaTerminatedPhase 2Hackensack Meridian HealthNCT04700176Written as All-trans retinoic acidHow we know
- A Study of TAS1440 With ATRA in Subjects With r/r AMLTerminatedPhase 1Taiho Oncology, Inc.NCT04282668Written as TAS1440 + ATRAHow we know
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedPhase 1OHSU Knight Cancer InstituteNCT03878524Written as TretinoinHow we know
- Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaCompletedPhase 2University of Colorado, DenverNCT02403778Written as VESANOIDHow we know
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)CompletedPhase 1/2Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)NCT02842827Written as tretinoinHow we know
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaCompletedPhase 2SWOG Cancer Research NetworkNCT00551460Written as tretinoinHow we know
- NB2013-HR German (GPOH) / Dutch (DCOG) TrialTerminatedPhase 2University of CologneNCT02641782Written as Retinoic acidHow we know
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaCompletedPhase 3Children's Oncology GroupNCT00866918Written as TretinoinHow we know
Showing 20 of 33.
As the comparator · 11 — what is tested is compared with Tretinoin
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingPhase 3Quetzal TherapeuticsNCT07504458Written as QTX-2101 + ATRAHow we know
- Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for AcneRecruitingPhase 2Shenzhen People's HospitalNCT07366229Written as Tretinoin cream 0.1%How we know
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne VulgarisCompletedPhase 1Sun Pharmaceutical Industries, Inc.NCT07469228Written as RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04%How we know
- Treatment of Striae Distensae With Fractional Radiofrequency and Topical TretinoinCompletedPhase 2Merete HaedersdalNCT05461755Written as Topical TretinoinHow we know
- Retinyl Palmitate-loaded Ethosomes in Acne VulgarisCompletedPhase 2Assiut UniversityNCT04080869Written as TretinoinHow we know
- A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne VulgarisCompletedEarly Phase 1Taro Pharmaceuticals USANCT04883736Written as RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1%How we know
- MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3CompletedPhase 1Sol-Gel Technologies, Ltd.NCT04059523Written as Retin-A® 0.1% CreamHow we know
- Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne VulgarisCompletedPhase 4Wake Forest UniversityNCT01047189Written as tretinoin 0.025% creamHow we know
- A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT GelCompletedPhase 3Stiefel, a GSK CompanyNCT00689117Written as Tretinoin Gel (tretinoin)How we know
- Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of AgingCompletedNot applicableCosmetique Active InternationalNCT00974480Written as Tretinoin (Rejuva-A)How we know
- Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular RemissionCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00962767Written as ATRA plus 6-MP and MTXHow we know
What changed recently
From the registry's own updates since Oct 21, 2026.
Results posted1
Stopped1
- A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHLTerminatedNov 17, 2026NCT06484920
Newly registered2
- Salicylic Acid Solution Versus Tretinoin 0.05% Cream for Treating Plane WartsNov 10, 2026NCT07927920
- Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaNov 9, 2026NCT07926607
Codes
What other systems call Tretinoin · ClinicalTrials.gg INT008346
- MeSH (NLM) D014212TretinoinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5688UTC01RTRETINOINConfirmed FDA, NLM, Wikidata
- RxNorm 10753Confirmed FDA, Wikidata
- Wikidata Q29417tretinoinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C900TretinoinOne source FDA
- DrugBank DB00755One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014212 | Tretinoin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5688UTC01R | TRETINOIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10753 | — | Confirmed FDA, Wikidata |
| Wikidata | Q29417 | tretinoin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C900 | Tretinoin | One source FDA |
| DrugBank | DB00755 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.